Using Neuropharmaceuticals for Cognitive Enhancement: Policy and Regulatory Issues
- 333 Downloads
This chapter provides an overview of policy and regulatory issues relating to the use of neuropharmaceuticals for cognitive enhancement in normal persons without a cognitive disorder. It draws on experience with a range of policy and regulatory approaches to alcohol, tobacco, pharmaceutical drugs, and illicit drugs and focuses on approaches that target rates of drug use in the population as a whole. The focus on regulatory interventions for the control of neuropharmaceuticals is important because a range of pharmaceutical drugs is often reportedly used and advocated for enhancement purposes. We also examine how more public health interventions such as awareness raising, education, and stigmatization could be used as preventive strategies to reduce the use, and harm associated with the use, of neuropharmaceuticals for cognitive enhancement.
KeywordsIllicit Drug Public Health Intervention Regulatory Approach Cognitive Enhancement Pharmaceutical Drug
- Academy of Medical Sciences. (2008). Brain science, addiction and drugs. London: United Kingdom Academy of Medical Sciences.Google Scholar
- Australian Press Council. (2001). Guideline: Drugs and drug addiction, http://www.presscouncil.org.au/document-search/guideline-drugs-and-drug-addiction/?LocatorGroupID=662&LocatorFormID=677&FromSearch=1. Advisory Guidelines. Accessed 5 Nov 2012.
- Babor, T., Caulkins, J., Edwards, G., Fischer, B., Foxcroft, D., Humphreys, K., & Strang, J. (2010). Drug policy and the public good. Oxford: Oxford University Press.Google Scholar
- British Medical Association. (2007). Boosting your brainpower: Ethical aspects of cognitive enhancements. London: BMA.Google Scholar
- Forlini, C., Gauthier, S., & Racine, E. (2013). Should physicians prescribe cognitive enhancers to healthy individuals? Canadian Medical Association Journal. Online ahead of print: 10.1503/cmaj.121508.Google Scholar
- Government of Quebec. (2009). Psychotropic drugs and expanded uses: An ethical perspective (Position Statement) Quebec: Commission de l’éthique, de la science et de la technologie.Google Scholar
- Outram, S. M., & Racine, E. (2011b). Examining reports and policies on cognitive enhancement: Approaches, rationale, and recommendations. Accountability in Research, 18(5), 323–341.Google Scholar
- Racine, E. (2010). Pragmatic neuroethics: Improving treatment and understanding of the mind-brain. Cambridge, MA: The MIT Press.Google Scholar
- Sandberg, A., & Savulescu, J. (2011). The social and economic impacts of cognitive enhancement. In J. Savulescu, R. ter Meulen, & G. Kahane (Eds.), Enhancing human capacities. Oxford, UK: Blackwell.Google Scholar
- Savulescu, J., & Bostrom, N. (Eds.). (2009). Human enhancement. Oxford: Oxford University Press.Google Scholar